scholarly journals THE EFFICACY AND SAFETY OF BENRALIZUMAB IN JAPANESE PATIENTS WITH SEVERE ASTHMA: A MULTICENTER STUDY

Respirology ◽  
2019 ◽  
Vol 24 (S2) ◽  
pp. 199-199
Keyword(s):  
Severe Asthma ◽  
Multicenter Study ◽  
Japanese Patients ◽  
Efficacy And Safety

FRI0141 Retention Rate and Discontinuation Due to Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis Receiving Adalimumab Therapy: A Multicenter Study

2015 ◽  
Vol 74 (Suppl 2) ◽  
pp. 472.2-473
Author(s):  
Y. Hattori ◽  
A. Kaneko ◽  
D. Kida ◽  
Y. Hirano ◽  
T. Fujibayashi ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Multicenter Study ◽  
Retention Rate ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Adalimumab Therapy

scholarly journals Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study

2020 ◽  
Vol 69 (4) ◽  
pp. 578-587
Author(s):  
Yuji Tohda ◽  
Yoichi Nakamura ◽  
Takao Fujisawa ◽  
Motohiro Ebisawa ◽  
Kazuhiko Arima ◽  
...  
Keyword(s):  
Severe Asthma ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Phase 3

Efficacy And Safety Of Omalizumab In Japanese Patients With Persistent Allergic Severe Asthma - Experience In Japan

2011 ◽  
Author(s):  
Yohei Yatagai ◽  
Takefumi Saito ◽  
Shimao Fukai ◽  
Akimasa Sekine ◽  
Yukiko Miura ◽  
...  
Keyword(s):  
Severe Asthma ◽  
Japanese Patients ◽  
Efficacy And Safety

scholarly journals Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn’s Disease Who Lost Response to Maintenance Therapy

2017 ◽  
Vol 2 (4) ◽  
pp. 228-235 ◽  
Author(s):  
Satoshi Motoya ◽  
Mamoru Watanabe ◽  
Kori Wallace ◽  
Andreas Lazar ◽  
Yasuko Nishimura ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Maintenance Therapy ◽  
Dose Escalation ◽  
Japanese Patients ◽  
Efficacy And Safety

scholarly journals Long‐term (52‐week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT ‐2 study

2021 ◽  
Author(s):  
Eiichi Araki ◽  
Chantal Mathieu ◽  
Toshihiko Shiraiwa ◽  
Hajime Maeda ◽  
Hiroki Ikeda ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Therapy ◽  
Subgroup Analysis ◽  
Japanese Patients ◽  
Efficacy And Safety
Sign in / Sign up

Export Citation Format

Share Document